Airna Corp.
- Address
- 1 Kendall Square Building 300
Sponsor Overview
Specializations
Alpha-1 Antitrypsin Deficiency
Airna Corp. focuses on clinical research in Alpha-1 Antitrypsin Deficiency, a genetic disorder associated with impaired alpha-1 antitrypsin function and related organ complications. The sponsor’s trial activity is centered on therapeutic development for this rare disease area, with interest in conditions affecting lung and liver health.
- Genetic rare disease
- Alpha-1 antitrypsin biology
- Pulmonary disease
- Hepatic disease
The research portfolio reflects a therapeutic emphasis on addressing the underlying biology of AATD and its systemic consequences.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Phase 1 Study of AIR-001 in Adults with Alpha-1 Antitrypsin Deficiency |  Germany Ireland Portugal Spain Sweden The Netherlands | Not Yet Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 11 sites across their trial portfolio.
Therapeutic Focus
- 1.Congenital, Hereditary, and Neonatal Diseases and Abnormalities1 trial165 other sponsors
- 2.Digestive System Diseases1 trial280 other sponsors
- 3.Respiratory Tract Diseases1 trial277 other sponsors
Partnered Research Centres
11 centres- Address
- Beaumont Road, Beaumont, D09 V2N0 Dublin
- Address
- Avenida Valdecilla Sn, 39008 Santander
- Address
- Passeig De La Vall D'Hebron 119-129, 08035 Barcelona
- Address
- Eugeniavagen 3, 171 64 Solna
- Address
- Albinusdreef 2, 2333 ZA Leiden
- Address
- Thiemstrasse 111, Spremberger Vorstadt, 03048 Cottbus
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Airna Corp..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.